
RenovoRx Closes $12.1 Million Public Offering of Common Stock
RenovoRx Closes $12.1 Million Public Offering of Common Stock RenovoRx, Inc. (Nasdaq: RNXT), a life sciences company focused on developing targeted oncology therapies, has successfully closed its previously announced $12.1…